Skip to main content
. 2019 Dec 24;9:19749. doi: 10.1038/s41598-019-55929-7

Table 2.

Characteristics and sexual practices associated with bacterial diversity of the vaginal microbiota.

Characteristic n women reporting exposure, n intervals exposure reported
(N = 100 women and 360 intervals)
Coeff. (95% CI)a P valuea Adj Coeff. (95% CI)b P valueb
Self-reported past history of BV
   No 78, 285 ref ref
   Yes 22, 75 0.28 (0.06,0.50) 0.013 0.26 (0.04,0.48) 0.018
Longitudinal characteristicsc
Any smokingd,e
   No 47, 210 ref ref
   Yes 53, 149 0.18 (0.01,0.35) 0.036 0.08 (−0.09,0.25) 0.352
Any douchinge
   No 94, 351 ref
   Yes 6, 8 0.50 (−0.02,1.01) 0.060
Number of SP
   0 3, 38f ref
   1 67, 270f 0.03 (−0.23,0.29) 0.818
   ≥2 30, 52f 0.36 (0.04,0.67) 0.027
Frequency of sex
   Once/month or less 14, 118g ref ref
   Several times/month 36, 131g 0.17 (−0.02,0.36) 0.074 0.13 (−0.05,0.31) 0.164
   Several times/week 50, 111g 0.30 (0.10,0.51) 0.003 0.20 (0.00,0.41) 0.049
   Sex with NPh
   No 60, 300 ref ref
   Yes 40, 60 0.49 (0.30,0.68) <0.001 0.41 (0.21,0.60) <0.001
Sexual practices with an FSPi
Any receptive oral vaginal sex
   Noj,e 15, 138 ref ref
   Yes 85, 221 0.24 (0.08,0.40) 0.003 0.15 (−0.02,0.31) 0.076
Any digital anal sex
   Noj,e 77, 317 ref
   Yes 23, 41 0.32 (0.08,0.57) 0.010
Sharing of sex toyse
   No toys/washed/condoms usedj 58, 272 ref
   Unwashed 42, 87 0.18 (−0.00,0.37) 0.051
Sexual practices with an MSPk
Any vaginal sex
   Nol, e 86, 321 ref
   Yes 14, 38 0.07 (−0.21,0.35) 0.637
Self-reported symptoms
Self-reported abnormal vaginal discharge and/or odour
   No 72, 317 ref
   Yes 28, 43 0.32 (0.09,0.55) 0.007

Abbreviations: BV, bacterial vaginosis; SP, sexual partner (may refer to FSP or MSP); NP, new partner (may refer to FSP or MSP); FSP, female sexual partner; MSP, male sexual partner

Missing data for variables included in this analysis occurred in <0.5% of intervals.

aUnivariate GEE linear regression, where participant ID is panel variable. The regression coefficient represents the mean difference of Shannon diversity between the reference and comparison group/s for each characteristic/practice investigated.

bMultivariable GEE linear regression, where participant ID is panel variable.

cLongitudinal characteristics were measured as any exposure over the prior study interval (~90 days). No significant associations were identified between Shannon diversity and either hormonal contraceptive use or recent menses.

dThere was no dose-response relationship between smoking and Shannon diversity.

eMissing data from a maximum of two intervals for some variables.

fFor women reporting different numbers of sexual partners in two or more intervals, the category representing the highest number of sexual partners has been used to calculate n women reporting exposure.

gFor women reporting different frequencies of sexual activity in two or more intervals, the most frequent category has been used to calculate n women reporting exposure.

hSex with a new partner with who first sexual contact was within 90 days.

iNo significant associations were identified between Shannon diversity and the following sexual practices with an FSP: Any digital vaginal sex from an FSP, any receptive oral anal sex from an FSP and current FSP with BV symptoms. These practices have been left out to simplify the table.

jOr did not have a FSP.

kNo significant associations were identified between Shannon diversity and the following sexual practices with an MSP: Condoms used for vaginal sex, vaginal sex after anal sex, any receptive oral vaginal sex from an MSP, any digital vaginal sex from an MSP, any anal sex from an MSP. These practices have been left out to simplify the table.

lOr did not have a MSP.